nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Hypotensive—Furosemide—dilated cardiomyopathy	0.0262	0.0404	CcSEcCtD
Nabilone—CNR1—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.0177	0.0504	CbGpPWpGaD
Nabilone—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.0162	0.0251	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.015	0.0426	CbGpPWpGaD
Nabilone—CNR1—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.0135	0.0384	CbGpPWpGaD
Nabilone—Apathy—Furosemide—dilated cardiomyopathy	0.0134	0.0206	CcSEcCtD
Nabilone—Flat affect—Furosemide—dilated cardiomyopathy	0.0132	0.0204	CcSEcCtD
Nabilone—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0128	0.0197	CcSEcCtD
Nabilone—Ataxia—Spironolactone—dilated cardiomyopathy	0.012	0.0185	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0118	0.0334	CbGpPWpGaD
Nabilone—Gastritis—Spironolactone—dilated cardiomyopathy	0.0113	0.0174	CcSEcCtD
Nabilone—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.011	0.017	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0106	0.03	CbGpPWpGaD
Nabilone—Drug interaction—Furosemide—dilated cardiomyopathy	0.0103	0.0159	CcSEcCtD
Nabilone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00982	0.0152	CcSEcCtD
Nabilone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00913	0.0141	CcSEcCtD
Nabilone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00854	0.0132	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00829	0.0235	CbGpPWpGaD
Nabilone—Mental disability—Furosemide—dilated cardiomyopathy	0.00829	0.0128	CcSEcCtD
Nabilone—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00789	0.0122	CcSEcCtD
Nabilone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00772	0.0119	CcSEcCtD
Nabilone—Thirst—Furosemide—dilated cardiomyopathy	0.00728	0.0112	CcSEcCtD
Nabilone—Neck pain—Lisinopril—dilated cardiomyopathy	0.00725	0.0112	CcSEcCtD
Nabilone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00712	0.011	CcSEcCtD
Nabilone—Wheezing—Lisinopril—dilated cardiomyopathy	0.00696	0.0107	CcSEcCtD
Nabilone—Malaise—Spironolactone—dilated cardiomyopathy	0.00692	0.0107	CcSEcCtD
Nabilone—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00687	0.0106	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00678	0.0193	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00678	0.0193	CbGpPWpGaD
Nabilone—Photophobia—Lisinopril—dilated cardiomyopathy	0.00673	0.0104	CcSEcCtD
Nabilone—Irritability—Furosemide—dilated cardiomyopathy	0.00661	0.0102	CcSEcCtD
Nabilone—Urinary retention—Furosemide—dilated cardiomyopathy	0.00659	0.0102	CcSEcCtD
Nabilone—Discomfort—Spironolactone—dilated cardiomyopathy	0.00645	0.00996	CcSEcCtD
Nabilone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00641	0.00989	CcSEcCtD
Nabilone—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00633	0.00977	CcSEcCtD
Nabilone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00631	0.00974	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0063	0.0179	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00629	0.0179	CbGpPWpGaD
Nabilone—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00601	0.00927	CcSEcCtD
Nabilone—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00592	0.00914	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00585	0.0166	CbGpPWpGaD
Nabilone—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00571	0.00881	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00567	0.0161	CbGpPWpGaD
Nabilone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00557	0.00859	CcSEcCtD
Nabilone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00553	0.00854	CcSEcCtD
Nabilone—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00547	0.00844	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00539	0.0153	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00539	0.0153	CbGpPWpGaD
Nabilone—Drowsiness—Furosemide—dilated cardiomyopathy	0.00534	0.00824	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00532	0.0151	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00532	0.0151	CbGpPWpGaD
Nabilone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00531	0.00819	CcSEcCtD
Nabilone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00516	0.00796	CcSEcCtD
Nabilone—Face oedema—Lisinopril—dilated cardiomyopathy	0.00502	0.00775	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00501	0.0142	CbGpPWpGaD
Nabilone—Irritability—Lisinopril—dilated cardiomyopathy	0.00496	0.00766	CcSEcCtD
Nabilone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00495	0.00764	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00495	0.014	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00494	0.014	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00493	0.014	CbGpPWpGaD
Nabilone—Ataxia—Lisinopril—dilated cardiomyopathy	0.00489	0.00755	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00485	0.0138	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00484	0.0137	CbGpPWpGaD
Nabilone—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00475	0.00733	CcSEcCtD
Nabilone—Visual impairment—Furosemide—dilated cardiomyopathy	0.00462	0.00713	CcSEcCtD
Nabilone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00461	0.00712	CcSEcCtD
Nabilone—Gastritis—Lisinopril—dilated cardiomyopathy	0.0046	0.0071	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00459	0.013	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00459	0.013	CbGpPWpGaD
Nabilone—Eye disorder—Furosemide—dilated cardiomyopathy	0.00448	0.00692	CcSEcCtD
Nabilone—Tinnitus—Furosemide—dilated cardiomyopathy	0.00447	0.0069	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00446	0.0127	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00445	0.0126	CbGpPWpGaD
Nabilone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00443	0.00684	CcSEcCtD
Nabilone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00438	0.00676	CcSEcCtD
Nabilone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00428	0.00661	CcSEcCtD
Nabilone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00428	0.00661	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00423	0.012	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00423	0.012	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00415	0.0118	CbGpPWpGaD
Nabilone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00414	0.00639	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00411	0.0117	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00411	0.0117	CbGpPWpGaD
Nabilone—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.0041	0.00633	CcSEcCtD
Nabilone—Depression—Lisinopril—dilated cardiomyopathy	0.004	0.00617	CcSEcCtD
Nabilone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00398	0.00614	CcSEcCtD
Nabilone—Rash—Spironolactone—dilated cardiomyopathy	0.00395	0.00609	CcSEcCtD
Nabilone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00394	0.00609	CcSEcCtD
Nabilone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00393	0.00607	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00393	0.0112	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00393	0.0112	CbGpPWpGaD
Nabilone—Headache—Spironolactone—dilated cardiomyopathy	0.00392	0.00605	CcSEcCtD
Nabilone—Anaemia—Furosemide—dilated cardiomyopathy	0.00386	0.00595	CcSEcCtD
Nabilone—Agitation—Furosemide—dilated cardiomyopathy	0.00384	0.00592	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00382	0.0108	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00381	0.0108	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0038	0.0108	CbGpPWpGaD
Nabilone—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00378	0.00583	CcSEcCtD
Nabilone—Vertigo—Furosemide—dilated cardiomyopathy	0.00375	0.00579	CcSEcCtD
Nabilone—Leukopenia—Furosemide—dilated cardiomyopathy	0.00374	0.00577	CcSEcCtD
Nabilone—Nausea—Spironolactone—dilated cardiomyopathy	0.00372	0.00574	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0037	0.0105	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00367	0.0104	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.0036	0.0102	CbGpPWpGaD
Nabilone—Hallucination—Lisinopril—dilated cardiomyopathy	0.00358	0.00552	CcSEcCtD
Nabilone—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00357	0.00551	CcSEcCtD
Nabilone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00348	0.00536	CcSEcCtD
Nabilone—Confusional state—Furosemide—dilated cardiomyopathy	0.00343	0.0053	CcSEcCtD
Nabilone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00335	0.00518	CcSEcCtD
Nabilone—Shock—Furosemide—dilated cardiomyopathy	0.00335	0.00517	CcSEcCtD
Nabilone—Flushing—Lisinopril—dilated cardiomyopathy	0.00334	0.00515	CcSEcCtD
Nabilone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00329	0.00508	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00325	0.00924	CbGpPWpGaD
Nabilone—Anorexia—Furosemide—dilated cardiomyopathy	0.00325	0.00501	CcSEcCtD
Nabilone—Chills—Lisinopril—dilated cardiomyopathy	0.00323	0.00498	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00322	0.00915	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00322	0.00915	CbGpPWpGaD
Nabilone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00321	0.00496	CcSEcCtD
Nabilone—Hypotension—Furosemide—dilated cardiomyopathy	0.00318	0.00491	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00316	0.00897	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00309	0.00876	CbGpPWpGaD
Nabilone—Tension—Lisinopril—dilated cardiomyopathy	0.00307	0.00474	CcSEcCtD
Nabilone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00306	0.00472	CcSEcCtD
Nabilone—Nervousness—Lisinopril—dilated cardiomyopathy	0.00304	0.00469	CcSEcCtD
Nabilone—Back pain—Lisinopril—dilated cardiomyopathy	0.00303	0.00468	CcSEcCtD
Nabilone—Somnolence—Furosemide—dilated cardiomyopathy	0.00303	0.00467	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00299	0.00851	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00299	0.00851	CbGpPWpGaD
Nabilone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00296	0.00457	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00296	0.0084	CbGpPWpGaD
Nabilone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00295	0.00456	CcSEcCtD
Nabilone—Fatigue—Furosemide—dilated cardiomyopathy	0.00294	0.00453	CcSEcCtD
Nabilone—Tremor—Lisinopril—dilated cardiomyopathy	0.00293	0.00453	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00292	0.00828	CbGpPWpGaD
Nabilone—Pain—Furosemide—dilated cardiomyopathy	0.00291	0.0045	CcSEcCtD
Nabilone—Constipation—Furosemide—dilated cardiomyopathy	0.00291	0.0045	CcSEcCtD
Nabilone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00291	0.00448	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0029	0.00824	CbGpPWpGaD
Nabilone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00289	0.00447	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00288	0.00818	CbGpPWpGaD
Nabilone—Malaise—Lisinopril—dilated cardiomyopathy	0.00282	0.00436	CcSEcCtD
Nabilone—Vertigo—Lisinopril—dilated cardiomyopathy	0.00281	0.00434	CcSEcCtD
Nabilone—Syncope—Lisinopril—dilated cardiomyopathy	0.00281	0.00433	CcSEcCtD
Nabilone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00281	0.00433	CcSEcCtD
Nabilone—Leukopenia—Lisinopril—dilated cardiomyopathy	0.0028	0.00433	CcSEcCtD
Nabilone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00279	0.0043	CcSEcCtD
Nabilone—Palpitations—Lisinopril—dilated cardiomyopathy	0.00277	0.00427	CcSEcCtD
Nabilone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00275	0.00425	CcSEcCtD
Nabilone—Cough—Lisinopril—dilated cardiomyopathy	0.00273	0.00422	CcSEcCtD
Nabilone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00269	0.00416	CcSEcCtD
Nabilone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00269	0.00416	CcSEcCtD
Nabilone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00267	0.00411	CcSEcCtD
Nabilone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00267	0.00411	CcSEcCtD
Nabilone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00267	0.00411	CcSEcCtD
Nabilone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00266	0.0041	CcSEcCtD
Nabilone—Discomfort—Lisinopril—dilated cardiomyopathy	0.00263	0.00407	CcSEcCtD
Nabilone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00261	0.00402	CcSEcCtD
Nabilone—Confusional state—Lisinopril—dilated cardiomyopathy	0.00258	0.00398	CcSEcCtD
Nabilone—Infection—Lisinopril—dilated cardiomyopathy	0.00254	0.00392	CcSEcCtD
Nabilone—Shock—Lisinopril—dilated cardiomyopathy	0.00251	0.00388	CcSEcCtD
Nabilone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00251	0.00387	CcSEcCtD
Nabilone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00249	0.00385	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00248	0.00704	CbGpPWpGaD
Nabilone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00247	0.00381	CcSEcCtD
Nabilone—Asthenia—Furosemide—dilated cardiomyopathy	0.00244	0.00377	CcSEcCtD
Nabilone—Anorexia—Lisinopril—dilated cardiomyopathy	0.00244	0.00376	CcSEcCtD
Nabilone—Pruritus—Furosemide—dilated cardiomyopathy	0.00241	0.00372	CcSEcCtD
Nabilone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00239	0.00369	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00235	0.00667	CbGpPWpGaD
Nabilone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00233	0.0036	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00233	0.00359	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00232	0.00659	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00232	0.00659	CbGpPWpGaD
Nabilone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00231	0.00357	CcSEcCtD
Nabilone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00229	0.00354	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00229	0.0065	CbGpPWpGaD
Nabilone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00228	0.00352	CcSEcCtD
Nabilone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00227	0.00351	CcSEcCtD
Nabilone—Dizziness—Furosemide—dilated cardiomyopathy	0.00225	0.00348	CcSEcCtD
Nabilone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00225	0.00347	CcSEcCtD
Nabilone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00222	0.00343	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00222	0.00631	CbGpPWpGaD
Nabilone—Fatigue—Lisinopril—dilated cardiomyopathy	0.0022	0.0034	CcSEcCtD
Nabilone—Pain—Lisinopril—dilated cardiomyopathy	0.00219	0.00337	CcSEcCtD
Nabilone—Constipation—Lisinopril—dilated cardiomyopathy	0.00219	0.00337	CcSEcCtD
Nabilone—Vomiting—Furosemide—dilated cardiomyopathy	0.00217	0.00334	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00216	0.00613	CbGpPWpGaD
Nabilone—Rash—Furosemide—dilated cardiomyopathy	0.00215	0.00331	CcSEcCtD
Nabilone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00215	0.00331	CcSEcCtD
Nabilone—Headache—Furosemide—dilated cardiomyopathy	0.00213	0.00329	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00211	0.00598	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00211	0.00598	CbGpPWpGaD
Nabilone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00211	0.00325	CcSEcCtD
Nabilone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00209	0.00323	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00209	0.00593	CbGpPWpGaD
Nabilone—Nausea—Furosemide—dilated cardiomyopathy	0.00202	0.00312	CcSEcCtD
Nabilone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00202	0.00312	CcSEcCtD
Nabilone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00202	0.00312	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00196	0.00556	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0019	0.00539	CbGpPWpGaD
Nabilone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00188	0.00291	CcSEcCtD
Nabilone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00183	0.00283	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00182	0.00517	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00182	0.00517	CbGpPWpGaD
Nabilone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00181	0.00279	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00178	0.00507	CbGpPWpGaD
Nabilone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00175	0.0027	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00174	0.00495	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00169	0.00481	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00169	0.00481	CbGpPWpGaD
Nabilone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00169	0.00261	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00165	0.00469	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00165	0.00469	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00164	0.00466	CbGpPWpGaD
Nabilone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00163	0.00251	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00162	0.0046	CbGpPWpGaD
Nabilone—Rash—Lisinopril—dilated cardiomyopathy	0.00161	0.00249	CcSEcCtD
Nabilone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00161	0.00248	CcSEcCtD
Nabilone—Headache—Lisinopril—dilated cardiomyopathy	0.0016	0.00247	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00154	0.00436	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00154	0.00436	CbGpPWpGaD
Nabilone—Nausea—Lisinopril—dilated cardiomyopathy	0.00152	0.00234	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00149	0.00423	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0014	0.00398	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0014	0.00398	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00133	0.00377	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00131	0.00373	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00127	0.00361	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00126	0.00357	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00124	0.00353	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00124	0.00353	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00121	0.00343	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00119	0.00339	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00116	0.00329	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00114	0.00324	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00112	0.00318	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.0011	0.00312	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00103	0.00293	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000985	0.0028	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000977	0.00277	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000977	0.00277	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000957	0.00272	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000936	0.00266	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000908	0.00258	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000908	0.00258	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000894	0.00254	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000879	0.0025	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000791	0.00225	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00078	0.00222	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000751	0.00213	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000712	0.00202	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000705	0.002	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000673	0.00191	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000621	0.00176	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000612	0.00174	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000553	0.00157	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000543	0.00154	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000528	0.0015	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000467	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000426	0.00121	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000367	0.00104	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00032	0.00091	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000251	0.000714	CbGpPWpGaD
